Michael Bonney - Tekla Healthcare Insider

Tekla Healthcare Investors -- USA Fund  

USD 26.08  0.22  0.84%

Independent Trustee

Mr. Michael W. Bonney is Independent Trustee of HQ Healthcare Investors. Mr. Bonney was the Chief Executive Officer and member of the Board of Directors of Cubist Pharmaceuticals, Inc. until December, 2014, providing each Fund with valuable insight into operating matters relating to biotech companies and the overall healthcare industry. He serves on the Valuation Committee and is Chairman of the Governance and Nominating Committee of each Fund
Age: 57  Executive Since 2011      
Bonney is also a Director of Alnylam Pharmaceuticals, Inc. and is Chairman of the Board of Trustees of Bates College. He holds a BA degree from Bates College.

Management Performance (%)

Fund Summary

The fund is listed under null category and is part of null family.

Did you try this?

Run Premium Stories Now
   

Premium Stories

Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Hide  View All  Next  Launch Premium Stories
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Tekla Healthcare Investors to your portfolio

Top Management

Tekla Healthcare Inv Leadership Team
William Reardon, Executive, CPA
Michael Bonney, Executive
Oleg Pohotsky, Chairman, MBA
Laura Woodward, Executive, CPA
Lucinda Stebbins, Executive, CPA
Daniel Omstead, President
Uwe Reinhardt, Executive, Ph.D
Rakesh Jain, Executive

Fund Performance

Tekla Healthcare Performance Indicators